# OBIZUR

NDC: 0944-5001
Generic name: Antihemophilic Factor (Recombinant), Porcine Sequence
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20141023

FDA application: BLA125512

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0944-5001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0944-5001